Increased survival of mouse ependymoblastoma hosts previously treated with dehistonized tumor chromatin.
Half of the mice treated with dehistonized chromatin (protein-DNA complex) from a transplantable mouse ependymoblastoma before subcutaneous challenge with the syngeneic tumor survived twice as long as untreated animals.